GOG-0240 Solid Tumor Evaluation Form (Form D2MV2) Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer Source Form: NCI FormBuilder:

  1. 8/27/12 8/27/12 -
  2. 1/9/15 1/9/15 - Martin Dugas
Uploaded on:

January 9, 2015

To request one please log in.
License :
Creative Commons BY-NC 3.0 Legacy
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Cervical Cancer NCT00803062 On-Study - GOG-0240 Solid Tumor Evaluation Form (Form D2MV2) - 2728202v1.0

No Instruction available.

  1. StudyEvent: GOG-0240 Solid Tumor Evaluation Form (Form D2MV2)
    1. No Instruction available.
Header Module
Target Lesion(s) Evaluation
Did the patient have measurable disease at baseline
Method of Evaluation (*)
Non-target Lesion(s) Evaluation
Were there any non-target lesions reported at baseline (If no, skip to the next section)
Method of Evaluation (*)
New Target Lesion(s) At Follow-up Evaluation
Was the appearance of any new lesions documented (If no, skip to the Overall Response section below.)
Method of Evaluation (*)
Overall Response
Disease status at this assessment
Overall best confirmed response

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial